SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-20-002049
Accepted
2020-08-07 00:15:09
Documents
1
Effectiveness Date
2020-08-06
Registration Form
POS AM
Reference AccNo
0001140361-20-011896

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 604
  Complete submission text file 9999999995-20-002049.txt   1750
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: EFFECT | Act: 33 | File No.: 333-231764 | Film No.: 201083592
SIC: 2834 Pharmaceutical Preparations